KOSDAQFood & Beverage435570

ERCOHS Agricultural

₩7,680▲ 0.79%2026-11-18 close
Market Cap
₩58.5B
Turnover
₩30,894,910
Volume
4.1K
Shares out.
7.6M
PER
—
PBR
1.0×
EPS
-₩304
Dividend Yield
1.79%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩130 per share · Prices as of the 2026-11-18 close

01

Report overview

Sales Up Two Quarters, Operating Losses Persist

ERCOHS Agricultural's Q3 2026 revenue rose for a second straight quarter to KRW 11 billion, but operating losses have continued for five consecutive quarters, making profitability recovery the key item to track.

  1. 1

    Q3 2026 revenue of KRW 11 billion rose 21.9% year on year, but an operating loss of KRW 173 million persisted.

  2. 2

    Full-year 2025 operating profit fell 91.7% to KRW 270 million, and the company swung to a parent-shareholder net loss of KRW 6.19 billion.

  3. 3

    Operating margin declined from 9.3% in 2023 to 0.8% in 2025, with raw material and packaging cost increases and new investment costs cited as burdens.

  4. 4

    The debt ratio fell from 136.8% in 2023 to 85.0% in 2025, and total equity at end-2025 stood at KRW 53.9 billion.

  5. 5

    Growth drivers are the WCO31-based height-growth functional food and offline expansion into department stores and shopping malls; the company has only said the functional food launch is in preparation, without a timing.

02

Business structure

ERCOHS Agricultural is a baby-food-focused food tech company founded in 2014 and listed on KOSDAQ in February 2025. Its flagship brand LUSOL covers more than 160 baby food products, nutrition porridge and health functional foods, making infant food the core of the business.

According to company earnings commentary, the premium LUSOL The Prime line lifted sales in the first half of 2026. The company is also widening its scope with a plant-based substitute food brand and a plant-based bakery brand.

Distribution is shifting from a Homeplus-centred offline network toward department stores, shopping malls and outlets. In a December 2025 report, Kiwoom Securities said the company planned to open more than 20 department store, shopping mall and outlet locations in 2026 as Homeplus stores are withdrawn in stages.

Online, the products are sold through about 20 platforms including Coupang and 11st, and exports are expanding to China, Taiwan, Vietnam and the United States.

In functional foods, the company has secured exclusive rights to WCO31, a plant-based height-growth ingredient, and is preparing a height-growth health functional food launch.

The domestic infant food market appears to be a structure where large food companies and specialist small firms compete side by side, and ERCOHS is widening its footprint through product range and channel count.

Its revenue base is far smaller than large food groups such as CJ Cheiljedang and Otoki, so a single channel change carries a relatively large weight in results.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩9B-₩77,297,223−0.9%
2025Q4₩9.7B-₩100M−1.4%
2026Q1₩8.8B-₩600M−6.7%
2026Q2₩10.3B-₩500M−4.7%
2026Q3₩11B-₩200M−1.6%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2023₩33B₩3.1B₩1.8B9.3%5.8%136.8%
2024₩36.5B₩3.2B₩900M8.9%2.4%124.3%
2025₩35.6B₩300M-₩6.2B0.8%−11.5%85.0%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-14

04

Earnings analysis

On an annual basis, sales rose 10.4% from KRW 33 billion in 2023 to KRW 36.5 billion in 2024, then fell 2.3% to KRW 35.6 billion in 2025. Among 2023 to 2025, 2024 was the largest year for sales and 2023 the smallest.

Operating profit grew 4.9% from KRW 3.08 billion in 2023 to KRW 3.24 billion in 2024, then fell 91.7% to KRW 270 million in 2025, which was the smallest year of the three. Operating margin declined over the same period from 9.3% to 8.9% and then to 0.8%.

Net profit attributable to controlling shareholders fell 48.8% from KRW 1.82 billion in 2023 to KRW 934 million in 2024, and the company swung to a net loss of KRW 6.19 billion in 2025.

Net profit including non-controlling interests was KRW 434 million in 2023, KRW 934 million in 2024 and a net loss of KRW 6.19 billion in 2025. Operating cash flow fell from KRW 3.48 billion in 2023 and KRW 5.13 billion in 2024 to KRW 210 million in 2025.

Quarterly, Q3 2025 started with revenue of KRW 8.99 billion and an operating loss of KRW 77.3 million. Q4 2025 revenue rose 8.1% quarter on quarter to KRW 9.72 billion, but the operating loss widened to KRW 140 million.

Q1 2026 revenue fell 9.7% to KRW 8.77 billion with an operating loss of KRW 583 million, the largest loss in the period. Q2 2026 revenue rose 17.1% to KRW 10.3 billion and the operating loss narrowed to KRW 478 million.

Q3 2026 revenue reached KRW 11 billion, up 6.7% quarter on quarter and 21.9% year on year, and the operating loss narrowed further to KRW 173 million. For Q1 2026, Kiwoom Securities pointed to raw material price increases from late 2025 and higher packaging costs linked to Middle East geopolitical risk.

The same report said the company had not fully passed cost increases into product prices in order to protect market share. Over the most recent four quarters, Q4 2025 to Q3 2026, the net loss attributable to controlling shareholders totalled KRW 2.52 billion.

05

Industry analysis

According to a company announcement reported in the press, the children's health functional food market, which includes height-growth products, is about KRW 260 billion in size and grew more than 52% from 2020.

The same report, citing data from the Korea Health Functional Food Association, said growth of more than 10% a year is expected. ERCOHS describes this market as a blue ocean and is entering it with the WCO31-based product.

On costs, raw material prices have risen since the second half of 2025, and Middle East geopolitical risk has pushed up packaging costs, according to Kiwoom Securities in a June 2026 report.

On demand, Kiwoom Securities cited a recovery in infant food demand as a factor that would partly offset second-half cost pressure. Competition appears to pit large food companies' infant food lines against specialist smaller firms.

ERCOHS has expanded its LUSOL product range and channel count, and is now adding functional foods on that base. Across the industry, holding market share while passing on cost increases appears to be the common tension.

How the functional food market's growth translates into the company's sales will become visible in quarterly results after the launch.

06

Outlook

In a June 2026 report, Kiwoom Securities projected that expansion of offline channels and entry into health functional foods in the second half would serve as growth drivers. The same report also flagged the cost burden expected in the second half from higher input costs and investment spending.

The company is preparing a launch of the WCO31-based height-growth functional food, and for overseas markets it is pursuing wider export countries and partner discovery through 2026. At the time of its announcement, the company set a target of securing more than 50% share with this ingredient within two years.

It has also said it is discussing collaboration with overseas partners, including a Chinese listed company, and partners in Vietnam, Taiwan and Singapore. Expansion of department store and shopping mall locations and entry into warehouse clubs are presented as second-half 2026 tasks.

Because the functional food launch has no announced timing, when it will begin to contribute to sales is uncertain. Whether the company can pass cost increases through to product prices will be a key variable for second-half profitability.

The next checkpoint is the 2026 annual business report, which will show full-year 2026 operating margin. Whether new-business revenue becomes visible separately in quarterly disclosures after the launch is another item to track.

07

Valuation

PER
—
PBR
1.0×
ROE
-4.9%
EPS
-₩304
BPS
₩7,522
Dividend per share
₩130

Because the net loss attributable to controlling shareholders has continued over the most recent four quarters, the price-to-earnings ratio (PER) cannot be calculated. The price-to-book ratio (PBR) is below 1x, meaning the share price sits low relative to book equity.

All of the KRW 53.9 billion total equity at end-2025 belongs to controlling shareholders, so PBR comparisons rest on that capital base. Cash dividends are paid, so dividend yield also serves as a reference point alongside valuation.

Over several years, the company swung from profit in 2023 to a loss in 2025, and operating margin fell from 9.3% to 0.8%. The PER stays uncalculated while losses continue, and whether earnings turn positive again determines whether it can be computed.

A PBR below 1x is a fact from an asset-based comparison, and its meaning becomes clearer when read alongside the pace of profit recovery. The lower debt ratio of 85.0% is also part of the backdrop to the asset-based comparison.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-14

08

Bull factors

Sales up for two straight quarters

Q2 2026 revenue of KRW 10.3 billion rose 17.1% quarter on quarter, and Q3 revenue of KRW 11 billion grew 21.9% year on year. Company earnings commentary attributes part of the sales growth to the premium LUSOL The Prime line. Kiwoom Securities cited a recovery in infant food demand as a second-half positive.

Height-growth functional food as a new business

ERCOHS has secured exclusive rights to WCO31, a plant-based height-growth functional ingredient. According to the company announcement, the children's health functional food market including height-growth products is about KRW 260 billion. The company has set a goal of more than 50% share within two years and is discussing overseas partnerships.

Channel expansion and a lighter balance sheet

Plans call for more department store, shopping mall and outlet locations, along with wider warehouse club listings. The debt ratio fell from 136.8% in 2023 to 85.0% in 2025. Operating cash flow stayed positive at KRW 210 million in 2025.

09

Bear factors

Five straight quarters of operating losses

Operating losses have continued for five consecutive quarters, from Q3 2025 through Q3 2026. Operating margin was 0.8% in 2025, and the net loss attributable to controlling shareholders was KRW 6.19 billion.

Over the most recent four quarters the cumulative net loss attributable to controlling shareholders was KRW 2.52 billion. The operating loss narrowed from KRW 583 million in Q1 2026 to KRW 173 million in Q3 2026.

Cost pressure and limited price pass-through

Kiwoom Securities pointed to raw material price increases and higher packaging costs as cost burdens in Q1 2026. Its analysis said the company had not fully passed cost increases into product prices in order to protect market share. The same report expected continued cost pressure from input prices and investment spending in the second half.

Slower cash generation and new-investment costs

Operating cash flow dropped sharply in 2025 from the prior year, weakening the company's capacity to generate cash. Total liabilities stood at KRW 45.8 billion at end-2025. Company earnings commentary attributes weaker profitability partly to offline distribution and new-business investment costs.

10

Risk factors

Raw material and packaging prices

Raw material prices and packaging costs linked to Middle East geopolitical risk directly affect results. If price increases conflict with defending market share, the recovery in operating margin could be delayed. The degree to which cost increases are reflected in product prices may shift quarterly profit and loss.

Timing of the functional food business

The WCO31-based functional food has been reported as still in launch preparation. Product development and regulatory approval schedules could slip, leaving the timing of any contribution to results uncertain.

Overseas sales are at the partner-discovery stage, with discussions under way in China, Vietnam, Taiwan and Singapore.

Low free float

As of 19 October 2026, the largest shareholder group held 74.76% and the free float ratio was 24.13%. With a low free float, trading liquidity can be limited. The company's market capitalisation is also modest, so share price movements can be more sensitive to trading conditions.

11

What to watch next

  1. After December 2026 (launch timing not announced)

    Whether and when the WCO31-based height-growth functional food launches is the first indicator of progress in the new business. Whether it shows up in quarterly sales after launch is the next checkpoint.

  2. After December 2026 (schedule not fixed)

    Whether the expansion of department store and shopping mall locations and warehouse club listings shows up in quarterly sales is the checkpoint. How far the second-half 2026 expansion plan is executed links to the scale of the sales recovery.

  3. Around 31 March 2027

    The 2026 annual business report will disclose full-year 2026 operating margin and Q4 operating results. Whether margin recovers from 0.8% in 2025 is the key checkpoint at that time.

  4. Around 15 May 2027

    This is the deadline for the Q1 2027 quarterly report. Whether cost pass-through effects appear in profit and loss after the KRW 583 million operating loss of Q1 2026 is the checkpoint.

12

Overall view

ERCOHS Agricultural is a baby-food specialist whose Q3 2026 revenue rose to KRW 11 billion, up for a second straight quarter, showing a recovery in top-line momentum. Operating losses, however, have continued for five consecutive quarters since Q3 2025, and operating margin fell to 0.8% in 2025.

On the positive side are the premium product line, offline channel expansion, preparation of the WCO31-based height-growth functional food, and a balance sheet whose debt ratio fell to 85.0%.

On the negative side are raw material and packaging cost pressure, an analysis that cost increases were not fully passed on to prices, and a continuing net loss attributable to controlling shareholders. The profit contribution from the new business has not yet been confirmed in disclosures.

On valuation, PER cannot be calculated while losses persist, and PBR below 1x is the only factual comparison available. The next checkpoints are the operating margin in the 2026 annual business report, operating results in the Q1 2027 quarterly report, and the launch timing of the WCO31 product.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. comp.wisereport.co.kr
  2. news.nate.com
  3. m.news.nate.com
  4. kokstock.com
  5. sedaily.com
  6. markets.hankyung.com
  7. alphasquare.co.kr
  8. news.nate.com
  9. kr.tradingview.com
  10. tradingkey.com
  11. financialcontent.com
  12. panabee.com
  13. kr.investing.com
  14. investing.com
  15. finance.yahoo.com
  16. benzinga.com
  17. gurufocus.com
  18. news.alphastreet.com

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis